LH ▲ +0.1% - Labcorp Holdings Inc. $LH - Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity Labcorp Holdings saw a modest 0.1% gain today following the company's launch of the next generation of its Labcorp Global Trial Connect platform, designed to streamline clinical trial operations for sponsors and investigator sites. The incremental price movement suggests investors are taking a measured view of the product enhancement, which could help the company expand its clinical trial services business by reducing complexity for customers. While the platform upgrade represents a step forward in Labcorp's trial services offerings, the minimal stock reaction indicates the market is waiting for evidence of meaningful adoption or revenue impact. 31-AUG-2026 07:00 AM ET